Free Trial

Health Catalyst (HCAT) Competitors

Health Catalyst logo
$3.65 -0.10 (-2.67%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.83 +0.18 (+4.93%)
As of 07/18/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HCAT vs. YALA, GDYN, MOMO, FSLY, MGIC, BLND, DAVA, EVER, DSP, and DCBO

Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Yalla Group (YALA), Grid Dynamics (GDYN), Hello Group (MOMO), Fastly (FSLY), Magic Software Enterprises (MGIC), Blend Labs (BLND), Endava (DAVA), EverQuote (EVER), Viant Technology (DSP), and Docebo (DCBO). These companies are all part of the "computer software" industry.

Health Catalyst vs. Its Competitors

Health Catalyst (NASDAQ:HCAT) and Yalla Group (NYSE:YALA) are both small-cap computer software companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Health Catalyst currently has a consensus target price of $8.00, indicating a potential upside of 119.18%. Given Health Catalyst's stronger consensus rating and higher possible upside, research analysts plainly believe Health Catalyst is more favorable than Yalla Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
Yalla Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 4.7% of Yalla Group shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by insiders. Comparatively, 52.2% of Yalla Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Health Catalyst has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Yalla Group has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Yalla Group has a net margin of 40.94% compared to Health Catalyst's net margin of -23.34%. Yalla Group's return on equity of 20.67% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-23.34% -6.14% -2.74%
Yalla Group 40.94%20.67%18.17%

Yalla Group has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Yalla Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$306.58M0.83-$69.50M-$1.15-3.17
Yalla Group$339.68M3.43$135.68M$0.779.57

In the previous week, Health Catalyst had 2 more articles in the media than Yalla Group. MarketBeat recorded 2 mentions for Health Catalyst and 0 mentions for Yalla Group. Health Catalyst's average media sentiment score of 0.00 equaled Yalla Group'saverage media sentiment score.

Company Overall Sentiment
Health Catalyst Neutral
Yalla Group Neutral

Summary

Yalla Group beats Health Catalyst on 9 of the 15 factors compared between the two stocks.

Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCAT vs. The Competition

MetricHealth CatalystMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$261.01M$2.01B$5.55B$9.40B
Dividend YieldN/AN/A3.75%4.03%
P/E Ratio-3.1735.8128.0119.82
Price / Sales0.8315.81432.8198.20
Price / Cash10.6453.5936.1658.27
Price / Book0.618.708.125.65
Net Income-$69.50M-$63.71M$3.25B$257.91M
7 Day Performance-6.17%-0.54%1.68%3.38%
1 Month PerformanceN/A10.02%7.30%11.11%
1 Year Performance-49.72%8.71%32.89%18.99%

Health Catalyst Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCAT
Health Catalyst
4.1664 of 5 stars
$3.65
-2.7%
$8.00
+119.2%
-47.4%$261.01M$306.58M-3.171,500News Coverage
YALA
Yalla Group
N/A$7.02
+3.7%
N/A+65.8%$1.07B$339.68M9.12630
GDYN
Grid Dynamics
2.1479 of 5 stars
$12.32
-0.6%
$18.75
+52.2%
-12.4%$1.05B$350.57M102.684,730Gap Up
MOMO
Hello Group
2.9922 of 5 stars
$8.54
+0.8%
$9.00
+5.4%
+34.4%$1.02B$1.45B6.571,390
FSLY
Fastly
3.6123 of 5 stars
$7.06
+0.4%
$8.28
+17.2%
-8.0%$1.02B$543.68M-6.481,100
MGIC
Magic Software Enterprises
1.2111 of 5 stars
$20.98
+1.4%
$16.00
-23.7%
+87.8%$1.02B$552.52M27.613,787Gap Down
High Trading Volume
BLND
Blend Labs
3.806 of 5 stars
$3.45
-2.3%
$4.90
+42.0%
+7.3%$916.61M$162.02M-17.251,690News Coverage
DAVA
Endava
4.0882 of 5 stars
$15.01
-3.2%
$26.63
+77.4%
-57.4%$914.99M$932.88M39.5012,085News Coverage
Analyst Forecast
EVER
EverQuote
4.0771 of 5 stars
$24.72
+0.8%
$32.50
+31.5%
+2.3%$876.31M$500.19M24.24610Positive News
DSP
Viant Technology
2.5904 of 5 stars
$13.69
-0.7%
$21.00
+53.4%
+29.0%$862.17M$289.23M124.47350
DCBO
Docebo
3.8359 of 5 stars
$28.98
-1.6%
$44.13
+52.3%
-18.6%$853.97M$216.93M39.16730Positive News

Related Companies and Tools


This page (NASDAQ:HCAT) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners